Jean Adams v. Merck Sharp & Dohme Corp., et al
| NOVO NORDISK A/S, ELI LILLY AND COMPANY, MERCK SHARP & DOHME CORP., FKA Merck & Co. Inc. and AMYLIN PHARMACEUTICALS, INC. |
| JEAN ADAMS, On Behalf of Herself and All Other Similarly Situated Plaintiffs |
| In re: INCRETIN-BASED THERAPIES PRODUCTS LIABILITY LITIGATION |
| 21-55342 |
| April 9, 2021 |
| U.S. Court of Appeals, Ninth Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 17, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 MEDIATION ORDER FILED: This case is RELEASED from the Mediation Program. [12115810] (VS) [Entered: 05/17/2021 04:34 PM] |
| Filing 12 Streamlined request [11] by Appellant Jean Adams to extend time to file the brief is approved. Amended briefing schedule: Appellant Jean Adams opening brief due 08/18/2021. Appellees Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Corp. and Novo Nordisk A/S answering brief due 09/17/2021. The optional reply brief is due 21 days from the date of service of the answering brief. [12107671] (BG) [Entered: 05/10/2021 01:07 PM] |
| Filing 11 Filed (ECF) Streamlined request for extension of time to file Opening Brief by Appellant Jean Adams. New requested due date is 08/18/2021. [12107149] [21-55342] (Becker, Timothy) [Entered: 05/10/2021 09:56 AM] |
| Filing 10 Added Attorney(s) Timothy J. Becker for party(s) Appellant Jean Adams. [12100517] (RL) [Entered: 05/03/2021 04:27 PM] |
| Filing 9 Filed (ECF) notice of appearance of Timothy J. Becker (Johnson Becker, PLLC, 444 Cedar Street, Suite 1800, St. Paul, MN 55101) for Appellant Jean Adams. Date of service: 05/03/2021. (Party was previously proceeding with counsel.) [12100279] [21-55342] (Becker, Timothy) [Entered: 05/03/2021 03:12 PM] |
| Filing 8 MEDIATION ORDER FILED: By 05/10/2021, counsel to email Circuit Mediator regarding settlement potential. Include Ninth Circuit case name and number in subject line. This communication will be kept confidential, if requested, and should not be filed with the court. The existing briefing schedule remains in effect. SEE ORDER FOR DETAILS. [12088208] (VS) [Entered: 04/27/2021 10:45 AM] |
| Filing 7 Added Attorney(s) Ilana Hope Eisenstein for party(s) Appellee Novo Nordisk A/S. [12084051] (RL) [Entered: 04/22/2021 03:44 PM] |
| Filing 6 Filed (ECF) notice of appearance of Ilana Hope Eisenstein (DLA Piper LLP, 1650 Market Street, Suite 5000, Philadelphia, PA 19103) for Appellee Novo Nordisk A/S. Date of service: 04/22/2021. (Party was previously proceeding with counsel.) [12084037] [21-55342] (Eisenstein, Ilana) [Entered: 04/22/2021 03:39 PM] |
| Filing 5 Added Attorney(s) Paul Boehm for party(s) Appellee Merck Sharp & Dohme Corp.. [12082687] (RL) [Entered: 04/21/2021 03:54 PM] |
| Filing 4 Filed (ECF) notice of appearance of Paul Edward Boehm (Williams & Connolly LLP 725 Twelfth Street, NW Washington, DC 20005) for Appellee Merck Sharp & Dohme Corp.. Date of service: 04/21/2021. (Party was previously proceeding with counsel.) [12082659] [21-55342] (Boehm, Paul) [Entered: 04/21/2021 03:43 PM] |
| Filing 3 The Mediation Questionnaire for this case was filed on 04/16/2021. To submit pertinent confidential information directly to the Circuit Mediators, please use the following # link . Confidential submissions may include any information relevant to mediation of the case and settlement potential, including, but not limited to, settlement history, ongoing or potential settlement discussions, non-litigated party related issues, other pending actions, and timing considerations that may impact mediation efforts.[12077348]. [21-55342] (AD) [Entered: 04/16/2021 12:44 PM] |
| Filing 2 Filed (ECF) Appellant Jean Adams Mediation Questionnaire. Date of service: 04/16/2021. [12076618] [21-55342] (Johnson, Michael) [Entered: 04/16/2021 07:19 AM] |
| Filing 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. The schedule is set as follows: Appellant Jean Adams Mediation Questionnaire due on 04/16/2021. Transcript ordered by 05/07/2021. Transcript due 06/07/2021. Appellant Jean Adams opening brief due 07/19/2021. Appellees Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Corp. and Novo Nordisk A/S answering brief due 08/19/2021. Appellant's optional reply brief is due 21 days after service of the answering brief. [12069867] (RT) [Entered: 04/09/2021 03:48 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
